Q&A

Is there product liability coverage in a printers' E&O policy?
Product recalls are costing companies and insurers billions, and the numbers are expected to increase.
A third potential cancer-causing contaminant has been found in a widely used blood-pressure medicine, according to the U.S. Food and Drug Administration (FDA).
India-based generic-drug company Hetero Labs Ltd. discovered a chemical called NMBA in its version of losartan, the FDA said in a statement Friday. The contamination was found during heightened testing stirred by a far-reaching recall of generic blood-pressure drugs known as angiotensin II receptor blockers, or ARBs, that contain potential carcinogens NDMA and NDEA.
Already have an account? Sign In Now
Copyright © 2023 ALM Global, LLC. All Rights Reserved.